Autistic-like social deficits in hippocampal MeCP2 knockdown rat models are rescued by ketamine
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Autism or autism spectrum disorder (ASD) is a behavioral syndrome characterized by persistent deficits in social interaction, and repetitive patterns of behavior, interests, or activities. The gene encoding Methyl-CpG binding protein 2 (MeCP2) is one of a few exceptional genes of established causal effect in ASD. Although genetically engineered mice studies may shed light on how MeCP2 loss affects synaptic activity patterns across the whole brain, such studies are not considered practical in ASD patients due to the overall level of impairment, and are technically challenging in mice. For the first time, we show that hippocampal MeCP2 knockdown produces behavioral abnormalities associated with autism-like traits in rats, providing a new strategy to investigate the efficacy of therapeutics in ASD. Ketamine, an N-Methyl-D-aspartate (NMDA) blocker, has been proposed as a possible treatment for autism. Using the MeCP2 knockdown rats in conjunction with a rat model of valproic acid (VPA)-induced ASD, we examined gene expression and ASD behaviors upon ketamine treatment. We report that the core symptoms of autism in MeCP2 knockdown rats with social impairment recovered dramatically following a single treatment with ketamine.
Abstract
Autism or autism spectrum disorder (ASD) is a behavioral syndrome characterized by persistent deficits in social interaction, and repetitive patterns of behavior, interests, or activities. The gene encoding Methyl-CpG binding protein 2 (MeCP2) is one of a few exceptional genes of established causal effect in ASD. Although genetically engineered mice studies may shed light on how MeCP2 loss affects synaptic activity patterns across the whole brain, such studies are not considered practical in ASD patients due to the overall level of impairment, and are technically challenging in mice. For the first time, we show that hippocampal MeCP2 knockdown produces behavioral abnormalities associated with autism-like traits in rats, providing a new strategy to investigate the efficacy of therapeutics in ASD. Ketamine, an N-Methyl-D-aspartate (NMDA) blocker, has been proposed as a possible treatment for autism. Using the MeCP2 knockdown rats in conjunction with a rat model of valproic acid (VPA)-induced ASD, we examined gene expression and ASD behaviors upon ketamine treatment. We report that the core symptoms of autism in MeCP2 knockdown rats with social impairment recovered dramatically following a single treatment with ketamine.
참고문헌 (31)
- Faras H, "Autism spectrum disorders", Ann Saudi Med, 30, pp.295~300 (2010)
- Hodges H, "Autism spectrum disorder : definition, epidemiology, causes, and clinical evaluation", Transl Pediatr, 9, pp.S55~ (2020)
- Ramocki MB, "The MECP2duplication syndrome", Am J Med Genet A, 152A, pp.1079~1088 (2010)
- Samaco RC, "Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome", Nat Genet, 44, pp.206~211 (2012)
- Monteggia LM, "Meeting report : can we make animal models of human mental illness?", Biol Psychiatry, 84, pp.542~545 (2018)
- Lu H, "Loss and gain of MeCP2cause similar hippocampal circuit dysfunction that is rescued by deep brain stimulation in a rett syndrome mouse model", Neuron, 91, pp.739~747 (2016)
- Penzes P, "Dendritic spine pathology in neuropsychiatric disorders", Nat Neurosci, 14, pp.285~293 (2011)
- Guang S, "Synaptopathology involved in autism spectrum disorder", Front Cell Neurosci, 12, pp.470~ (2018)
- Katz DM, "N-Methyl-DAspartate Receptors, Ketamine, and Rett Syndrome : Something Special on the Road to Treatments?", Biol Psychiatry, 79, pp.710~712 (2016)
- Katz DM, "Rett syndrome : crossing the threshold to clinical translation", Trends Neurosci, 39, pp.100~113 (2016)
- Kron M, "Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment", J Neurosci, 32, pp.13860~13872 (2012)
- Silverman JL, "Behavioural phenotyping assays for mouse models of autism", Nat Rev Neurosci, 11, pp.490~502 (2010)
- Piven J, "Broader autism phenotype : evidence from a family history study of multiple-incidence autism families", Am J Psychiatry, 154, pp.185~190 (1997)
- Dawson G, "Defining the broader phenotype of autism : genetic, brain, and behavioral perspectives", Dev Psychopathol, 14, pp.581~611 (2002)
- Lu DH, "Impairment of social behaviors in Arhgef10 knockout mice", Mol Autism, 9, pp.11~ (2018)
- Li J, "Synaptic P-Rex1signaling regulates hippocampal long-term depression and autism-like social behavior", Proc Natl Acad Sci U S A, 112, pp.E6964~ (2015)
- Kim KC, "Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring", Mol Neurobiol, 49, pp.512~528 (2014)
- Busch RM, "Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTEN", Transl Psychiatry, 9, pp.253~ (2019)
- Lyu JW, "Reciprocal regulation of autism-related genes MeCP2 and PTEN via microRNAs", Sci Rep, 6, pp.20392~ (2016)
- Kwon CH, "Pten regulates neuronal arborization and social interaction in mice", Neuron, 50, pp.377~388 (2006)
- Lugo JN, "Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins", Front Mol Neurosci, 7, pp.27~ (2014)
- Jin J, "RNAi-induced down-regulation of Mecp2 expression in the rat brain", Int J Dev Neurosci, 26, pp.457~465 (2008)
- Meng X, "Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders", Elife, 5, pp.e14199~ (2016)
- Yoo T, "Shank3exons 14-16 deletion in glutamatergic neurons leads to social and repetitive behavioral deficits associated with increased cortical layer 2", 3 neuronal excitability, 2019, pp.13, 458~
- Bonsi P, "Postsynaptic autism spectrum disorder genes and synaptic dysfunction", Neurobiol Dis, 162, pp.105564~ (2021)
- Kurochkin I, "Metabolome signature of autism in the human prefrontal cortex", Commun Biol, 2, pp.234~ (2019)
- Sasaki T, "Postnatal development of dendritic structure of layer III pyramidal neurons in the medial prefrontal cortex of marmoset", Brain Struct Funct, 220, pp.3245~3258 (2015)
- Oga T, "Postnatal development of layer III pyramidal cells in the primary visual, inferior temporal, and prefrontal cortices of the marmoset", Front Neural Circuits, 7, pp.31~ (2013)
- Lee EJ, "NMDA receptor dysfunction in autism spectrum disorders", Curr Opin Pharmacol, 20, pp.8~13 (2015)
- 이윤진, "Striatal Inhibition of MeCP2 or TSC1 Produces Sociability Deficits and Repetitive Behaviors", Experimental Neurobiology, 27(6), pp.539~549 (2018), 한국뇌신경과학회
- Moy SS, "Sociability and preference for social novelty in five inbred strains : an approach to assess autistic-like behavior in mice", Genes Brain Behav, 3, pp.287~302 (2004)